Issue navigation
Volume 57, Issue 12, December 2018
EDITORIALS
The soul of Rheumatology
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2063–2064, https://doi.org/10.1093/rheumatology/key355
Can prediction models in primary care enable earlier diagnosis of rare rheumatic diseases?
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2065–2066, https://doi.org/10.1093/rheumatology/kex508
Evidence-based practice is the gold standard and should be adhered to at all times—or should it?
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2067–2069, https://doi.org/10.1093/rheumatology/kex509
Releasing the complement brakes: is myeloperoxidase the missing link between factor H and C5a in anti-neutrophil cytoplasmic antibody vasculitis?
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2070–2071, https://doi.org/10.1093/rheumatology/key126
REVIEWS
Comparative advantages of infrapatellar fat pad: an emerging stem cell source for regenerative medicine
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2072–2086, https://doi.org/10.1093/rheumatology/kex487
Metabolomics of osteoarthritis: emerging novel markers and their potential clinical utility
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2087–2095, https://doi.org/10.1093/rheumatology/kex497
CLINICAL SCIENCE
Biologic prescribing decisions following serious infection: results from the British Society for Rheumatology Biologics Register—Rheumatoid Arthritis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2096–2100, https://doi.org/10.1093/rheumatology/key198
Certolizumab pegol in the treatment of Takayasu arteritis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2101–2105, https://doi.org/10.1093/rheumatology/key197
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2106–2113, https://doi.org/10.1093/rheumatology/key213
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2114–2119, https://doi.org/10.1093/rheumatology/key188
Simultaneous occurrence of ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: a systematic review
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2120–2128, https://doi.org/10.1093/rheumatology/key211
Urate-lowering treatment and risk of total joint replacement in patients with gout
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2129–2139, https://doi.org/10.1093/rheumatology/key212
Familial Mediterranean fever in Chinese adult patients
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2140–2144, https://doi.org/10.1093/rheumatology/key218
Genetic association between adiposity and gout: a Mendelian randomization study
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2145–2148, https://doi.org/10.1093/rheumatology/key229
Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2149–2157, https://doi.org/10.1093/rheumatology/key222
Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2158–2166, https://doi.org/10.1093/rheumatology/key233
Prospective validation of the Juvenile Spondyloarthritis Disease Activity Index in children with enthesitis-related arthritis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2167–2171, https://doi.org/10.1093/rheumatology/key246
The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2172–2182, https://doi.org/10.1093/rheumatology/key224
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2183–2189, https://doi.org/10.1093/rheumatology/key237
Illness perceptions and their association with 2 year functional status and change in patients with hand osteoarthritis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2190–2199, https://doi.org/10.1093/rheumatology/key231
Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2200–2212, https://doi.org/10.1093/rheumatology/key242
BASIC AND TRANSLATIONAL SCIENCE
Myeloperoxidase influences the complement regulatory activity of complement factor H
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2213–2224, https://doi.org/10.1093/rheumatology/kex529
Dysbiosis of the buccal mucosa microbiome in primary Sjögren’s syndrome patients
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2225–2234, https://doi.org/10.1093/rheumatology/key215
Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2235–2241, https://doi.org/10.1093/rheumatology/key265
LETTERS TO THE EDITOR
CASE REPORTS
A case with tumour-induced osteomalacia misdiagnosed as axial spondyloarthritis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2242–2243, https://doi.org/10.1093/rheumatology/key255
High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2244–2246, https://doi.org/10.1093/rheumatology/key234
A patient with spondylarthropathy treated with TNF-α inhibitors presenting with clinical findings suspicious of metastatic cancer disease
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2246–2248, https://doi.org/10.1093/rheumatology/key226
MATTERS ARISING
Comment on: The multisystemic nature and natural history of joint hypermobility syndrome and Ehlers-Danlos syndrome in children
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2248–2250, https://doi.org/10.1093/rheumatology/key251
Comment on: The multisystemic nature and natural history of joint hypermobility syndrome and Ehlers–Danlos syndrome in children: reply
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2250–2251, https://doi.org/10.1093/rheumatology/key252
CLINICAL VIGNETTES
Hereditary exostosis missed by MRI
Rheumatology, Volume 57, Issue 12, December 2018, Page 2252, https://doi.org/10.1093/rheumatology/key177
Intracranial vasculitis in eosinophilic granulomatosis with polyangiitis
Rheumatology, Volume 57, Issue 12, December 2018, Page 2253, https://doi.org/10.1093/rheumatology/key178
GLOBAL NEWS ITEM
A new, free, multidisciplinary e-book on Ehlers-Danlos syndrome has recently been published
Rheumatology, Volume 57, Issue 12, December 2018, Page e57, https://doi.org/10.1093/rheumatology/key289
EDITOR’S ACKNOWLEDGEMENT
Editor’s Acknowledgement
Rheumatology, Volume 57, Issue 12, December 2018, Pages 2254–2259, https://doi.org/10.1093/rheumatology/key347
CORRIGENDUM
A patient with spondylarthropathy treated with TNF-α inhibitors presenting with clinical findings suspicious of metastatic cancer disease
Rheumatology, Volume 57, Issue 12, December 2018, Page 2260, https://doi.org/10.1093/rheumatology/key334
